Follow

Kancera AB

Nasdaq First North GM (Sweden)

Kancera AB develops drugs that counteract damage in acute and chronic inflammation. The fractalkin blockers KAND567 and KAND145 are developed to effectively counteract hyperinflamation in various disease states and thereby protect vital organs in conjunction with myocardial infarction and severe viral infections. Kancera is planning two phase II clinical trials, in covid-19 and in cardiac patients. The company conducts research and development within the Karolinska Institute Science Park in Stockholm.

Sector:
HEALTH CARE
>
Biotechnology
Healthcare
Exercise
Price
10.00 SEK
Exercise period(s)
01 Jun - 30 Nov 2021
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Show archived
Type
Ticker
ISIN
Market
SHARE
KAN
SE0015658570
Nasdaq First North GM
Sweden (SE)
Details of share in Kancera AB with ticker KAN
Status
Active
Order book id
Amount of instruments
47 419 547
Par value
Currency
SEK
Segment
First North Premier
First trading date
25 Feb 2011
Type
Price
Pre-money
Time
Files
IPO
7.00 SEK
67.54M SEK
30 Nov 2010 - 31 Jan 2011
IPO in Kancera AB
Type
Price
Pre-money
Time
Files
Private placement
4.00 SEK
52.99M SEK
11 Jul 2011
Share issue in Kancera AB
Type
Price
Pre-money
Time
Files
Rights issue
2.30 SEK
34.84M SEK
22 May - 04 Jun 2012
Share issue in Kancera AB
Type
Price
Pre-money
Time
Files
Rights issue
0.69 SEK
12.94M SEK
13 Nov - 18 Dec 2012
Share issue in Kancera AB
Type
Price
Pre-money
Time
Files
Rights issue
0.50 SEK
16.13M SEK
25 Nov - 11 Dec 2013
Share issue in Kancera AB
Type
Price
Pre-money
Time
Files
Exercise
0.75 SEK
57.4M SEK
01 May - 31 May 2014
Option exercise terms for KAN TO 1
Type
Price
Pre-money
Time
Files
Rights issue
2.50 SEK
246.37M SEK
06 May - 27 May 2015
Share issue in Kancera AB
Type
Price
Pre-money
Time
Files
Rights issue
2.50 SEK
276.75M SEK
10 May - 25 May 2016
Share issue in Kancera AB
Type
Price
Pre-money
Time
Files
Exercise
5.00-6.00 SEK
01 Oct 2016 - 30 Jun 2017
01 Jul 2017 - 30 Apr 2018
Option exercise terms for KAN TO 2
Type
Price
Pre-money
Time
Files
Rights issue
1.80 SEK
243.88M SEK
12 May - 30 May 2017
Share issue in Kancera AB
Type
Price
Pre-money
Time
Files
Rights issue
1.20 SEK
178.36M SEK
04 May - 22 May 2018
Share issue in Kancera AB
Type
Price
Pre-money
Time
Files
Exercise
1.95 SEK
22 May - 22 Nov 2019
Option exercise terms for KAN TO 3
Type
Price
Pre-money
Time
Files
Directed issue
28 Jun 2019
Share issue in Kancera AB
Type
Price
Pre-money
Time
Files
Directed issue
19 Aug 2019
Type
Price
Pre-money
Time
Files
Rights issue
0.39 SEK
81.83M SEK
17 Mar - 31 Mar 2020
Share issue in Kancera AB
Type
Price
Pre-money
Time
Files
Exercise
8.50 SEK
403.07M SEK
04 May - 30 Sep 2020
01 Mar - 31 Mar 2021
Option exercise terms for KAN TO4
Type
Price
Pre-money
Time
Files
Directed issue
12.70 SEK
619.82M SEK
19 Apr 2021
Share issue in Kancera AB
Type
Price
Pre-money
Time
Files
Rights issue
12.70 SEK
640.19M SEK
05 May - 19 May 2021
Share issue in Kancera AB
Type
Ticker
ISIN
Market
OPTION
KAN TO5
SE0013914785
Nasdaq First North GM
Sweden (SE)
Details of option in Kancera AB with ticker KAN TO5
Status
Active
Order book id
196718
Amount of instruments
157 369 119
Currency
SEK
Segment
First North Premier
Trading period
13 May 2020 - 26 Nov 2021
Terms
Three (3) warrants of series TO5 entitles to subscribe for one (1) new share in the Company during the subscription period from June 2021 until November 2021 for SEK 1.00.
Update (22.02.2021): Thirty (30) warrants of series TO5 entitles the holder to subscribe for one (1) new share in the Company for SEK 10.0.
Type
Price
Pre-money
Time
Files
Exercise
10.00 SEK
01 Jun - 30 Nov 2021
Option exercise terms for KAN TO5
Type
Ticker
ISIN
Market
SHARE
KAN
SE0003622265
Nasdaq First North GM
Sweden (SE)
Details of share in Kancera AB with ticker KAN
Status
Archived
Order book id
Amount of instruments
436 404 617
Par value
Currency
SEK
Segment
First North Premier
First trading date
25 Feb 2011
Type
Price
Pre-money
Time
Files
IPO
7.00 SEK
67.54M SEK
30 Nov 2010 - 31 Jan 2011
IPO in Kancera AB
Type
Price
Pre-money
Time
Files
Private placement
4.00 SEK
52.99M SEK
11 Jul 2011
Share issue in Kancera AB
Type
Price
Pre-money
Time
Files
Rights issue
2.30 SEK
34.84M SEK
22 May - 04 Jun 2012
Share issue in Kancera AB
Type
Price
Pre-money
Time
Files
Rights issue
0.69 SEK
12.94M SEK
13 Nov - 18 Dec 2012
Share issue in Kancera AB
Type
Price
Pre-money
Time
Files
Rights issue
0.50 SEK
16.13M SEK
25 Nov - 11 Dec 2013
Share issue in Kancera AB
Type
Price
Pre-money
Time
Files
Rights issue
2.50 SEK
246.37M SEK
06 May - 27 May 2015
Share issue in Kancera AB
Type
Price
Pre-money
Time
Files
Rights issue
2.50 SEK
276.75M SEK
10 May - 25 May 2016
Share issue in Kancera AB
Type
Price
Pre-money
Time
Files
Rights issue
1.80 SEK
243.88M SEK
12 May - 30 May 2017
Share issue in Kancera AB
Type
Price
Pre-money
Time
Files
Rights issue
1.20 SEK
178.36M SEK
04 May - 22 May 2018
Share issue in Kancera AB
Type
Price
Pre-money
Time
Files
Directed issue
28 Jun 2019
Share issue in Kancera AB
Type
Price
Pre-money
Time
Files
Directed issue
19 Aug 2019
Type
Price
Pre-money
Time
Files
Rights issue
0.39 SEK
81.83M SEK
17 Mar - 31 Mar 2020
Share issue in Kancera AB
Type
Ticker
ISIN
Market
SHARE
KAN
SE0015658570
Nasdaq First North GM
Sweden (SE)
Details of share in Kancera AB with ticker KAN
Status
Active
Order book id
Amount of instruments
47 419 547
Par value
Currency
SEK
Segment
First North Premier
Type
Price
Pre-money
Time
Files
Directed issue
12.70 SEK
619.82M SEK
19 Apr 2021
Share issue in Kancera AB
Type
Price
Pre-money
Time
Files
Rights issue
12.70 SEK
640.19M SEK
05 May - 19 May 2021
Share issue in Kancera AB
Type
Ticker
ISIN
Market
OPTION
KAN TO 1
SE0005560141
Nasdaq First North GM
Sweden (SE)
Details of option in Kancera AB with ticker KAN TO 1
Status
Archived
Order book id
99642
Amount of instruments
Currency
SEK
Trading period
29 Jan 2014 - 27 May 2014
Terms
Two (2) warrants entitles the holder to subscribe for one (1) new share in the Company for SEK 0.75 during the subscription period from May 01, 2014 until May 31, 2014.
Update (29.04.2014): Kancera announces terms and start for redemption of warrants of series TO 1.
Type
Price
Pre-money
Time
Files
Exercise
0.75 SEK
57.4M SEK
01 May - 31 May 2014
Option exercise terms for KAN TO 1
Type
Ticker
ISIN
Market
OPTION
KAN TO 2
SE0008321673
Nasdaq First North GM
Sweden (SE)
Details of option in Kancera AB with ticker KAN TO 2
Status
Archived
Order book id
124272
Amount of instruments
Currency
SEK
Trading period
11 Jul 2016 - 28 Apr 2018
Terms
Two (2) warrants entitles to subscribe for one (1) new share in the Company for SEK 5 during the subscription period from October 1, 2016 until June 30, 2017 and for SEK 6 during the subscription period up to and including April 30, 2018.
Update (30.06.2016): Conversion of BTU and first day of trading with warrant TO 2.
Update (02.05.2018): Kancera warrant of series TO 2.
Type
Price
Pre-money
Time
Files
Exercise
5.00-6.00 SEK
01 Oct 2016 - 30 Jun 2017
01 Jul 2017 - 30 Apr 2018
Option exercise terms for KAN TO 2
Type
Ticker
ISIN
Market
OPTION
KAN TO 3
SE0011167386
Nasdaq First North GM
Sweden (SE)
Details of option in Kancera AB with ticker KAN TO 3
Status
Archived
Order book id
157649
Amount of instruments
Currency
SEK
Segment
First North Premier
Trading period
09 Jul 2018 - 20 Nov 2019
Terms
Two (2) warrants entitles to subscribe for one (1) new share in the Company for SEK 1.95 during the subscription period from May 22, 2019 until November 22, 2019.
Type
Price
Pre-money
Time
Files
Exercise
1.95 SEK
22 May - 22 Nov 2019
Option exercise terms for KAN TO 3
Type
Ticker
ISIN
Market
OPTION
KAN TO4
SE0013914777
Nasdaq First North GM
Sweden (SE)
Details of option in Kancera AB with ticker KAN TO4
Status
Archived
Order book id
196717
Amount of instruments
179 269 322
Currency
SEK
Segment
First North Premier
Trading period
13 May 2020 - 26 Mar 2021
Terms
Two (2) warrants of series TO4 entitles to subscribe for a one (1) new share for SEK 0.47 during the May 2020, or for the price of SEK 0.85 per share during the March 2021.
Update (24.03.2020): Kancera proposes extended exercise period for warrant TO4, which will be issued in the ongoing Rights issue.
Update (15.09.2020): The redemption period for Kancera's warrants of series TO4 expires in September 2020.
Update (22.02.2021): Twenty (20) warrants of series TO4 entitles the holder to subscribe for one (1) new share in the Company for SEK 8.50.
Update (10.03.2021): The redemption period for Kancera's warrant TO4 expires in March 2021.
Type
Price
Pre-money
Time
Files
Exercise
8.50 SEK
403.07M SEK
04 May - 30 Sep 2020
01 Mar - 31 Mar 2021
Option exercise terms for KAN TO4
Type
Ticker
ISIN
Market
OPTION
KAN TO5
SE0013914785
Nasdaq First North GM
Sweden (SE)
Details of option in Kancera AB with ticker KAN TO5
Status
Active
Order book id
196718
Amount of instruments
157 369 119
Currency
SEK
Segment
First North Premier
Trading period
13 May 2020 - 26 Nov 2021
Terms
Three (3) warrants of series TO5 entitles to subscribe for one (1) new share in the Company during the subscription period from June 2021 until November 2021 for SEK 1.00.
Update (22.02.2021): Thirty (30) warrants of series TO5 entitles the holder to subscribe for one (1) new share in the Company for SEK 10.0.
Type
Price
Pre-money
Time
Files
Exercise
10.00 SEK
01 Jun - 30 Nov 2021
Option exercise terms for KAN TO5
People
Thomas Olin
CEO
Erik Nerpin
Chairman of the board
Håkan Mellstedt
Board member
Charlotte Edenius
Board member
Carl-Henrik Heldin
Board member
Anders Gabrielsen
Board member
Thomas Olin
Board member
Company Details
Sector
HEALTH CARE
Website

Address
Nanna Svartz Väg 4
Zip code
171 48
City/district
Solna
Country
Sweden (SE)
Registration number
556806-8851
LEI code
5493002P3RCOFW6HI207
First trade date
25 Feb 2011
Registration date
28 Apr 2010
Short name
Kancera

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More